Anthony Lombardo, MD
Ophthalmology · Indianapolis, INNPI 1538102512
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $8,432 of the $12,955 with a category attached, or 65.1%. 29 manufacturers reported payments, led by Lensar, Inc. at 51.9% of the total. Reporting peaked in 2020 at $4,329 and has fallen 76.9% since, to $1,000 in 2025. Among ophthalmology clinicians in IN with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 217 payments — averaging $59.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lensar, Inc.$7K
- Glaukos Corporation$2K
- Alcon$2K
- Johnson & Johnson Surgical Vision, Inc.$533
- AbbVie$445
- Rxsight Inc$368
- plus $2K from 23 others
What the payments were for
- Consulting fees$4,00031%
- Speaking & faculty fees$5244%
- Food & beverage$8,43265%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lensar, Inc. | 26 | $6,720 |
| Glaukos Corporation | 25 | $1,853 |
| Alcon | 56 | $1,524 |
| Johnson & Johnson Surgical Vision, Inc. | 15 | $533 |
| AbbVie(2 entities) | 17 | $445 |
| Rxsight Inc | 14 | $368 |
| Novartis | 13 | $313 |
| Bausch & Lomb Americas Inc. | 9 | $195 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 4 | $160 |
| Mallinckrodt Hospital Products Inc. | 6 | $159 |
| Tarsus Pharmaceuticals, Inc. | 6 | $105 |
| Dompe US, Inc. | 4 | $87 |
| Biotissue Holdings Inc. | 4 | $66 |
| Staar Surgical Company | 1 | $64 |
| Lombart Brothers, Inc. | 1 | $55 |
| Sight Sciences, Inc. | 2 | $34 |
| Thea Pharma Inc. | 2 | $34 |
| Harrow Eye, LLC | 1 | $34 |
| ANI Pharmaceuticals, Inc. | 1 | $33 |
| Akorn, Inc. | 1 | $25 |
| Sun Pharmaceutical Industries Inc. | 1 | $25 |
| Oyster Point Pharma, Inc. | 1 | $22 |
| Carl Zeiss Meditec USA, Inc. | 1 | $19 |
| Shire North American Group Inc | 1 | $15 |
| Eyevance Pharmaceuticals LLC | 1 | $15 |
| Novo Nordisk | 1 | $14 |
| Beaver-visitec International, Inc. | 1 | $14 |
| Ocular Therapeutix, Inc. | 1 | $12 |
| Kala Pharmaceuticals, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LENSAR LASER SYSTEM$6,516
- iStent infinite Trabecular Micro-Bypass System Model iS3$839
- RADIUS$302
- Tecnis 1-piece IOL$247
- iDose$205
- iS3-iStent infiniteTrabecular Micro-Bypass System Model iS3$173
- Clareon$129
- Hydrus Microstent$125
- Voyager DSLT$125
- Tecnis Symfony IOL$124
- Tecnis Multifocal Family of 1-piece IOLS$123
- Tecnis Toric 1-piece IOL$123
- RXSIGHT CONTACT LENS$115
- RXSIGHT INJECTOR CARTRIDGE$115
- RXSIGHT INJECTOR HANDPIECE$115
- RXSIGHT LIGHT DELIVERY DEVICE (LDD)$115
- LIGHT ADJUSTABLE LENS (LAL)$115
- Wavelight Refractive Suite$113
- DURYSTA$108
- VYZULTA$107
How this compares
$12,955 in reported general payments places this provider in the 90th percentile of 266 ophthalmology providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 403 | $22,228 |
| RestasisCyclosporine | 13 | $12,164 |
| Ketorolac Tromethamine | 227 | $6,276 |
| AlrexLoteprednol Etabonate | 12 | $4,663 |
| Loteprednol Etabonate | 19 | $4,617 |
| MoxifloxacinMoxifloxacin Hcl | 155 | $4,496 |
| Brimonidine Tartrate-TimololBrimonidine Tartrate/Timolol | 11 | $3,042 |
| Ofloxacin | 156 | $2,266 |
| Atropine Sulfate | 58 | $1,839 |
| ValacyclovirValacyclovir Hcl | 14 | $1,205 |
| Fluorometholone | 32 | $981 |
| Latanoprost | 57 | $845 |
| Diclofenac Sodium | 22 | $274 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieRestasis | $445 | $12,16413 claims |
| Bausch & Lomb, A Division Of Bausch Health US, LLCAlrex, Loteprednol Etabonate | $160 | $9,28031 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 266 ophthalmology providers in Indiana.
Other ophthalmology in Indianapolis
- Kevin WaltzIndianapolis$199K
- Janet HummerIndianapolis$96K
- Francis PriceIndianapolis$67K
- Michael OrrIndianapolis$26K
- Matthew FengIndianapolis$22K
- John LindIndianapolis$20K
- Shaohui LiuIndianapolis$19K
- John LatonaIndianapolis$18K
- William WhitsonIndianapolis$15K
- Thierry WilbrandtIndianapolis$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.